Targeted Drugs for NSCLC Market Report

Global Targeted Drugs for NSCLC Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 20, 2021
  • PAGES：206
  • REPORT CODE：GMM648672
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Targeted Drugs for NSCLC is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Targeted Drugs for NSCLC market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Targeted Drugs for NSCLC industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Targeted Drugs for NSCLC Market Segmentations:

    By Players:

    • Fujifilm Kyowa Kirin Biologics

    • Teva

    • Novartis

    • Glenmark Pharmaceuticals

    • Genvio Pharma Limited

    • Cipla

    • Biocon

    • Amgen

    • Roche

    • ImClone Systems ‎(Eli Lilly)

    • Celgene Corporation

    • Pfizer

    • Hetero Drugs

    • ARIAD Pharmaceuticals (Takeda)

    • Reliance Lifesciences

    • Incepta Pharmaceuticals

    • BeiGene

    • Mylan

    • Natco Pharma

    • Drug International Limted

    • OSI Pharmaceuticals

    • Boehringer-Ingelheim

    • AstraZeneca

    • Allergan

    • Beacon Pharma Limited

    By Types:

    • Target EGFR

    • Target ALK

    • Target HER2

    • Target ROS1

    • Target BRAF

    • Target MEK

    • Target VEGFR2

    • Target VEGF

    • Target MET

    By End-User:

    • Squamous Cell Carcinoma of NSCLC

    • Adenocarcinoma of NSCLC

    • Large Cell Carcinoma of NSCLC

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Targeted Drugs for NSCLC Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target EGFR from 2014 to 2026

      • 1.3.2 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target ALK from 2014 to 2026

      • 1.3.3 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target HER2 from 2014 to 2026

      • 1.3.4 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target ROS1 from 2014 to 2026

      • 1.3.5 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target BRAF from 2014 to 2026

      • 1.3.6 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target MEK from 2014 to 2026

      • 1.3.7 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target VEGFR2 from 2014 to 2026

      • 1.3.8 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target VEGF from 2014 to 2026

      • 1.3.9 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Target MET from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Squamous Cell Carcinoma of NSCLC from 2014 to 2026

      • 1.4.2 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Adenocarcinoma of NSCLC from 2014 to 2026

      • 1.4.3 Global Targeted Drugs for NSCLC Market Size and Growth Rate of Large Cell Carcinoma of NSCLC from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Targeted Drugs for NSCLC Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Targeted Drugs for NSCLC Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Targeted Drugs for NSCLC by Major Types

      • 3.4.1 Targeted Drugs for NSCLC Market Size and Growth Rate of Target EGFR

      • 3.4.2 Targeted Drugs for NSCLC Market Size and Growth Rate of Target ALK

      • 3.4.3 Targeted Drugs for NSCLC Market Size and Growth Rate of Target HER2

      • 3.4.4 Targeted Drugs for NSCLC Market Size and Growth Rate of Target ROS1

      • 3.4.5 Targeted Drugs for NSCLC Market Size and Growth Rate of Target BRAF

      • 3.4.6 Targeted Drugs for NSCLC Market Size and Growth Rate of Target MEK

      • 3.4.7 Targeted Drugs for NSCLC Market Size and Growth Rate of Target VEGFR2

      • 3.4.8 Targeted Drugs for NSCLC Market Size and Growth Rate of Target VEGF

      • 3.4.9 Targeted Drugs for NSCLC Market Size and Growth Rate of Target MET

    4 Segmentation of Targeted Drugs for NSCLC Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Targeted Drugs for NSCLC by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Targeted Drugs for NSCLC in Squamous Cell Carcinoma of NSCLC

      • 4.4.2 Market Size and Growth Rate of Targeted Drugs for NSCLC in Adenocarcinoma of NSCLC

      • 4.4.3 Market Size and Growth Rate of Targeted Drugs for NSCLC in Large Cell Carcinoma of NSCLC

    5 Market Analysis by Major Regions

    • 5.1 Global Targeted Drugs for NSCLC Production Analysis by Major Regions

    • 5.2 Global Targeted Drugs for NSCLC Consumption Analysis by Major Regions

    • 5.3 Global Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis

    6 Product Commodity of Targeted Drugs for NSCLC Market in Major Countries

    • 6.1 Top 5 Export Countries in Targeted Drugs for NSCLC market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Targeted Drugs for NSCLC market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Targeted Drugs for NSCLC market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Targeted Drugs for NSCLC market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Targeted Drugs for NSCLC market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Targeted Drugs for NSCLC market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Targeted Drugs for NSCLC Landscape Analysis

    • 7.1 North America Targeted Drugs for NSCLC Landscape Analysis by Major Types

    • 7.2 North America Targeted Drugs for NSCLC Landscape Analysis by Major End-Users

    • 7.3 North America Targeted Drugs for NSCLC Landscape Analysis by Major Countries

      • 7.3.1 United States Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 7.3.2 Canada Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 7.3.3 Mexico Targeted Drugs for NSCLC Market Volume and Growth Rate

    8 Europe Targeted Drugs for NSCLC Landscape Analysis

    • 8.1 Europe Targeted Drugs for NSCLC Landscape Analysis by Major Types

    • 8.2 Europe Targeted Drugs for NSCLC Landscape Analysis by Major End-Users

    • 8.3 Europe Targeted Drugs for NSCLC Landscape Analysis by Major Countries

      • 8.3.1 Germany Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.2 UK Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.3 France Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.4 Italy Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.6 Spain Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.7 Belgium Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.8 Poland Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.9 Russia Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 8.3.10 Turkey Targeted Drugs for NSCLC Market Volume and Growth Rate

    9 Asia Pacific Targeted Drugs for NSCLC Landscape Analysis

    • 9.1 Asia Pacific Targeted Drugs for NSCLC Landscape Analysis by Major Types

    • 9.2 Asia Pacific Targeted Drugs for NSCLC Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Targeted Drugs for NSCLC Landscape Analysis by Major Countries

      • 9.3.1 China Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 9.3.2 Japan Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 9.3.4 India Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 9.3.6 South Korea Targeted Drugs for NSCLC Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Targeted Drugs for NSCLC Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Targeted Drugs for NSCLC Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Targeted Drugs for NSCLC Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Targeted Drugs for NSCLC Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 10.3.2 Brazil Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 10.3.3 Nigeria Targeted Drugs for NSCLC Market Volume and Growth Rate

      • 10.3.4 South Africa Targeted Drugs for NSCLC Market Volume and Growth Rate 

      • 10.3.5 Argentina Targeted Drugs for NSCLC Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Fujifilm Kyowa Kirin Biologics

      • 11.1.1 Fujifilm Kyowa Kirin Biologics Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Teva

      • 11.2.1 Teva Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Novartis

      • 11.3.1 Novartis Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Glenmark Pharmaceuticals

      • 11.4.1 Glenmark Pharmaceuticals Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Genvio Pharma Limited

      • 11.5.1 Genvio Pharma Limited Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Cipla

      • 11.6.1 Cipla Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Biocon

      • 11.7.1 Biocon Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Amgen

      • 11.8.1 Amgen Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Roche

      • 11.9.1 Roche Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 ImClone Systems ‎(Eli Lilly)

      • 11.10.1 ImClone Systems ‎(Eli Lilly) Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Celgene Corporation

      • 11.11.1 Celgene Corporation Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Pfizer

      • 11.12.1 Pfizer Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Hetero Drugs

      • 11.13.1 Hetero Drugs Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 ARIAD Pharmaceuticals (Takeda)

      • 11.14.1 ARIAD Pharmaceuticals (Takeda) Company Profile and Recent Development

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Reliance Lifesciences

      • 11.15.1 Reliance Lifesciences Company Profile and Recent Development

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Incepta Pharmaceuticals

      • 11.16.1 Incepta Pharmaceuticals Company Profile and Recent Development

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 BeiGene

      • 11.17.1 BeiGene Company Profile and Recent Development

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Mylan

      • 11.18.1 Mylan Company Profile and Recent Development

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Natco Pharma

      • 11.19.1 Natco Pharma Company Profile and Recent Development

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction

    • 11.20 Drug International Limted

      • 11.20.1 Drug International Limted Company Profile and Recent Development

      • 11.20.2 Market Performance

      • 11.20.3 Product and Service Introduction

    • 11.21 OSI Pharmaceuticals

      • 11.21.1 OSI Pharmaceuticals Company Profile and Recent Development

      • 11.21.2 Market Performance

      • 11.21.3 Product and Service Introduction

    • 11.22 Boehringer-Ingelheim

      • 11.22.1 Boehringer-Ingelheim Company Profile and Recent Development

      • 11.22.2 Market Performance

      • 11.22.3 Product and Service Introduction

    • 11.23 AstraZeneca

      • 11.23.1 AstraZeneca Company Profile and Recent Development

      • 11.23.2 Market Performance

      • 11.23.3 Product and Service Introduction

    • 11.24 Allergan

      • 11.24.1 Allergan Company Profile and Recent Development

      • 11.24.2 Market Performance

      • 11.24.3 Product and Service Introduction

    • 11.25 Beacon Pharma Limited

      • 11.25.1 Beacon Pharma Limited Company Profile and Recent Development

      • 11.25.2 Market Performance

      • 11.25.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 122 Figures and 137 Tables)

    • Figure Product Picture

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target EGFR from 2014 to 2026

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target ALK from 2014 to 2026

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target HER2 from 2014 to 2026

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target ROS1 from 2014 to 2026

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target BRAF from 2014 to 2026

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target MEK from 2014 to 2026

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target VEGFR2 from 2014 to 2026

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target VEGF from 2014 to 2026

    • Figure Targeted Drugs for NSCLC Market Size and Growth Rate of Target MET from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Squamous Cell Carcinoma of NSCLC from 2014 to 2026

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Adenocarcinoma of NSCLC from 2014 to 2026

    • Figure Global Targeted Drugs for NSCLC Market Size and Growth Rate of Large Cell Carcinoma of NSCLC from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Targeted Drugs for NSCLC Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Targeted Drugs for NSCLC Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Targeted Drugs for NSCLC

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Targeted Drugs for NSCLC by Different Types from 2014 to 2026

    • Table Consumption Share of Targeted Drugs for NSCLC by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Target EGFR

    • Figure Market Size and Growth Rate of Target ALK

    • Figure Market Size and Growth Rate of Target HER2

    • Figure Market Size and Growth Rate of Target ROS1

    • Figure Market Size and Growth Rate of Target BRAF

    • Figure Market Size and Growth Rate of Target MEK

    • Figure Market Size and Growth Rate of Target VEGFR2

    • Figure Market Size and Growth Rate of Target VEGF

    • Figure Market Size and Growth Rate of Target MET

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Targeted Drugs for NSCLC by Different End-Users from 2014 to 2026

    • Table Consumption Share of Targeted Drugs for NSCLC by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Squamous Cell Carcinoma of NSCLC

    • Figure Market Size and Growth Rate of Adenocarcinoma of NSCLC

    • Figure Market Size and Growth Rate of Large Cell Carcinoma of NSCLC

    • Table Global Targeted Drugs for NSCLC Production by Major Regions

    • Table Global Targeted Drugs for NSCLC Production Share by Major Regions

    • Figure Global Targeted Drugs for NSCLC Production Share by Major Regions in 2014

    • Figure Global Targeted Drugs for NSCLC Production Share by Major Regions in 2018

    • Figure Global Targeted Drugs for NSCLC Production Share by Major Regions in 2026

    • Table Global Targeted Drugs for NSCLC Consumption by Major Regions

    • Table Global Targeted Drugs for NSCLC Consumption Share by Major Regions

    • Figure Global Targeted Drugs for NSCLC Consumption Share by Major Regions in 2014

    • Figure Global Targeted Drugs for NSCLC Consumption Share by Major Regions in 2018

    • Figure Global Targeted Drugs for NSCLC Consumption Share by Major Regions in 2026

    • Table North America Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis

    • Table Europe Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Targeted Drugs for NSCLC Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Targeted Drugs for NSCLC market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Targeted Drugs for NSCLC market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Targeted Drugs for NSCLC market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Targeted Drugs for NSCLC market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Targeted Drugs for NSCLC Consumption by Types from 2014 to 2026

    • Table North America Targeted Drugs for NSCLC Consumption Share by Types from 2014 to 2026

    • Figure North America Targeted Drugs for NSCLC Consumption Share by Types in 2014

    • Figure North America Targeted Drugs for NSCLC Consumption Share by Types in 2018

    • Figure North America Targeted Drugs for NSCLC Consumption Share by Types in 2026

    • Table North America Targeted Drugs for NSCLC Consumption by End-Users from 2014 to 2026

    • Table North America Targeted Drugs for NSCLC Consumption Share by End-Users from 2014 to 2026

    • Figure North America Targeted Drugs for NSCLC Consumption Share by End-Users in 2014

    • Figure North America Targeted Drugs for NSCLC Consumption Share by End-Users in 2018

    • Figure North America Targeted Drugs for NSCLC Consumption Share by End-Users in 2026

    • Table North America Targeted Drugs for NSCLC Consumption by Major Countries from 2014 to 2026

    • Table North America Targeted Drugs for NSCLC Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Targeted Drugs for NSCLC Consumption Share by Major Countries in 2014

    • Figure North America Targeted Drugs for NSCLC Consumption Share by Major Countries in 2018

    • Figure North America Targeted Drugs for NSCLC Consumption Share by Major Countries in 2026

    • Figure United States Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Targeted Drugs for NSCLC Consumption by Types from 2014 to 2026

    • Table Europe Targeted Drugs for NSCLC Consumption Share by Types from 2014 to 2026

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by Types in 2014

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by Types in 2018

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by Types in 2026

    • Table Europe Targeted Drugs for NSCLC Consumption by End-Users from 2014 to 2026

    • Table Europe Targeted Drugs for NSCLC Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by End-Users in 2014

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by End-Users in 2018

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by End-Users in 2026

    • Table Europe Targeted Drugs for NSCLC Consumption by Major Countries from 2014 to 2026

    • Table Europe Targeted Drugs for NSCLC Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by Major Countries in 2014

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by Major Countries in 2018

    • Figure Europe Targeted Drugs for NSCLC Consumption Share by Major Countries in 2026

    • Figure Germany Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure France Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Targeted Drugs for NSCLC Consumption by Types from 2014 to 2026

    • Table Asia Pacific Targeted Drugs for NSCLC Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by Types in 2014

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by Types in 2018

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by Types in 2026

    • Table Asia Pacific Targeted Drugs for NSCLC Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Targeted Drugs for NSCLC Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by End-Users in 2014

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by End-Users in 2018

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by End-Users in 2026

    • Table Asia Pacific Targeted Drugs for NSCLC Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Targeted Drugs for NSCLC Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Targeted Drugs for NSCLC Consumption Share by Major Countries in 2026

    • Figure China Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandTargeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure India Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Targeted Drugs for NSCLC Consumption Share by Major Countries in 2026

    • Figure GCC Countries Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Targeted Drugs for NSCLC Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Fujifilm Kyowa Kirin Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujifilm Kyowa Kirin Biologics

    • Figure Sales and Growth Rate Analysis of Fujifilm Kyowa Kirin Biologics

    • Figure Revenue and Market Share Analysis of Fujifilm Kyowa Kirin Biologics

    • Table Product and Service Introduction of Fujifilm Kyowa Kirin Biologics

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Glenmark Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Glenmark Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Glenmark Pharmaceuticals

    • Table Product and Service Introduction of Glenmark Pharmaceuticals

    • Table Company Profile and Development Status of Genvio Pharma Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genvio Pharma Limited

    • Figure Sales and Growth Rate Analysis of Genvio Pharma Limited

    • Figure Revenue and Market Share Analysis of Genvio Pharma Limited

    • Table Product and Service Introduction of Genvio Pharma Limited

    • Table Company Profile and Development Status of Cipla

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla

    • Figure Sales and Growth Rate Analysis of Cipla

    • Figure Revenue and Market Share Analysis of Cipla

    • Table Product and Service Introduction of Cipla

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of ImClone Systems ‎(Eli Lilly)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ImClone Systems ‎(Eli Lilly)

    • Figure Sales and Growth Rate Analysis of ImClone Systems ‎(Eli Lilly)

    • Figure Revenue and Market Share Analysis of ImClone Systems ‎(Eli Lilly)

    • Table Product and Service Introduction of ImClone Systems ‎(Eli Lilly)

    • Table Company Profile and Development Status of Celgene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

    • Figure Sales and Growth Rate Analysis of Celgene Corporation

    • Figure Revenue and Market Share Analysis of Celgene Corporation

    • Table Product and Service Introduction of Celgene Corporation

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Hetero Drugs

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hetero Drugs

    • Figure Sales and Growth Rate Analysis of Hetero Drugs

    • Figure Revenue and Market Share Analysis of Hetero Drugs

    • Table Product and Service Introduction of Hetero Drugs

    • Table Company Profile and Development Status of ARIAD Pharmaceuticals (Takeda)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ARIAD Pharmaceuticals (Takeda)

    • Figure Sales and Growth Rate Analysis of ARIAD Pharmaceuticals (Takeda)

    • Figure Revenue and Market Share Analysis of ARIAD Pharmaceuticals (Takeda)

    • Table Product and Service Introduction of ARIAD Pharmaceuticals (Takeda)

    • Table Company Profile and Development Status of Reliance Lifesciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reliance Lifesciences

    • Figure Sales and Growth Rate Analysis of Reliance Lifesciences

    • Figure Revenue and Market Share Analysis of Reliance Lifesciences

    • Table Product and Service Introduction of Reliance Lifesciences

    • Table Company Profile and Development Status of Incepta Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Incepta Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Incepta Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Incepta Pharmaceuticals

    • Table Product and Service Introduction of Incepta Pharmaceuticals

    • Table Company Profile and Development Status of BeiGene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BeiGene

    • Figure Sales and Growth Rate Analysis of BeiGene

    • Figure Revenue and Market Share Analysis of BeiGene

    • Table Product and Service Introduction of BeiGene

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Natco Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Natco Pharma

    • Figure Sales and Growth Rate Analysis of Natco Pharma

    • Figure Revenue and Market Share Analysis of Natco Pharma

    • Table Product and Service Introduction of Natco Pharma

    • Table Company Profile and Development Status of Drug International Limted

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Drug International Limted

    • Figure Sales and Growth Rate Analysis of Drug International Limted

    • Figure Revenue and Market Share Analysis of Drug International Limted

    • Table Product and Service Introduction of Drug International Limted

    • Table Company Profile and Development Status of OSI Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OSI Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of OSI Pharmaceuticals

    • Figure Revenue and Market Share Analysis of OSI Pharmaceuticals

    • Table Product and Service Introduction of OSI Pharmaceuticals

    • Table Company Profile and Development Status of Boehringer-Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer-Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer-Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer-Ingelheim

    • Table Product and Service Introduction of Boehringer-Ingelheim

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Company Profile and Development Status of Beacon Pharma Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beacon Pharma Limited

    • Figure Sales and Growth Rate Analysis of Beacon Pharma Limited

    • Figure Revenue and Market Share Analysis of Beacon Pharma Limited

    • Table Product and Service Introduction of Beacon Pharma Limited


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US